Pharmacyte Biotech Inc (OTCMKTS:PMCB), better known for its initiatives in the development of diabetes and cancer with the help of Cell-in-a-box, announced that its senior management team was interviewed. According to reports, company’s CEO Kenneth L. Waggoner, JD, and COO Dr. Gerald W. Crabtree, Ph.D. have got featured in the September issue of PharmaVOICE Magazine.
Both of them shared their views on the role of business leaders in Oncology field for the development of clinical trials in the best way possible. The complete article named “Oncology KOLS: An Important Piece of the Puzzle” can be read online at PharmaVOICE’s website.
Inputs From Business Leaders
While talking to reporters, Waggoner said that the company is actively working on the development of clinical trials for advanced pancreatic cancer. There are many patients around the world suffering from this disease, and Pharmacyte is fully committed to finding a solution to cure this disease as soon as possible.
The company relies on the expert knowledge shared by its well-known physicians in oncology, who take care of designing, planning and execution of the trials. Waggoner is thankful to all of them for supporting the company and successfully leading it to a growth path.
Pharmacyte seeks to continue its growth at a great pace and become a market leader in the pharmaceutical field over the course of the time.
Meanwhile, another pharmaceutical company Natural Alternatives International, Inc. (NASDAQ:NAII) has announced that its well-acclaimed Natural Health Event will now be available for the public. It’s the first time when the company has taken such a step in 2015. As per the reports, the event will commence with the presentation of famous health expert Dr. Thomas O’Bryan.
It’s the continuous hard work and commitment to serve the community in the best way possible that has earned USANA Health Sciences, Inc. (NYSE:USNA) a place among top 50 companies in Utah. The list is comprised of top companies that have outperformed the market on the back of extraordinary growth rate. It’s the continuous 8th time when USANA has found its place in Fast 50 list.
